Insulet Corporation PODD

Company Overview

Insulet Corporation is a medical device company focused on the development, manufacture, and commercialization of insulin delivery systems for people with diabetes. The company operates within the diabetes medical devices and digital health industries, with a primary emphasis on tubeless insulin pump technology. Its core product is the Omnipod® Insulin Management System, a wearable, disposable insulin delivery device designed to simplify insulin therapy for individuals with Type 1 diabetes and insulin-dependent Type 2 diabetes.

Founded in 2000, Insulet differentiated itself through its tubeless, wearable insulin pump design, which contrasts with traditional tethered pumps. The company’s revenue is primarily driven by recurring sales of disposable pods and associated controller and software ecosystems. Insulet has evolved from an early-stage device innovator into a globally scaled diabetes technology company, benefiting from increased adoption of automated insulin delivery and integration with continuous glucose monitoring (CGM) platforms.